Cigarette Alternatives Rise at TPE
By Angel Abcede, Senior Editor/Tobacco, CSP
LAS VEGAS — Enthusiasm about innovation in the tobacco category was palpable at the 2018 Tobacco Plus Expo (TPE), as conference speakers revealed promising numbers for vaping devices, OTP and the cannabis compound known as cannabinoid or CBD.
Panelists such as Nik Modi, tobacco analyst for RBC Capital Markets LLC, New York, said he’s seeing innovation in chewing tobacco, moist smokeless, snus and other tobacco products (OTP), as well as electronic cigarettes and vaping devices.
“I’ve been negative about e-cigarettes in the past, not because [I didn’t see] the opportunity, but I thought it was too early. I thought the science was not good enough, but things are changing,” Modi told about 200 conference attendees at a session sponsored by Lakeville, Minn.-based NATO.
Modi and other industry speakers were in Las Vegas for the TPE educational sessions and trade show that ran from Jan. 30-Feb. 1. They pointed out a number of bright spots within the tobacco category.
Here are a few of those insights, as well as several product finds from the trade-show floor:
Where there’s smoke, there’s fire. Well, these days there’s fire where there’s vaping, at least according to numbers from Pittsburgh-based Management Science Associates (MSA). Don Burke, senior vice president for MSA, said numbers are up, especially with vaporizers and the types of “closed” vaping systems where users replace a module (called a mod or pod) of self-contained e-liquid with another one when it runs out.
MSA tracks products shipped to stores, which doesn’t necessarily translate directly to product sold. But in his numbers specific to c-stores, a 13-week moving average ending in third-quarter 2017 compared to the previous year showed that volume movement for vaporizers rose by 635%, while tobacco outlets saw an even greater rise at 1,492%.
Burke pointed to a substantial surge in products from San Francisco-based Juul Labs. He said an MSA study tracking Google searches and product throughput saw both a strong correlation and spike in movement. “It’s the most dramatic … we’ve seen for any individual product,” he said.
Enthusiasm for innovation in the category was evident. For example, manufacturer Space Jam Juice, San Clemente, Calif., was eager to show attendees its new closed-system vaping device called The Byrd.
At the same time, news at the federal level seemed to cast a shadow on alternative devices. In late January, a special committee created by the U.S. Food and Drug Administration (FDA) rejected most of the harm-reduction claims made by New York-based Philip Morris International (PMI) regarding its heat-not-burn device called iQOS. While the Tobacco Product Scientific Advisory Committee agreed that the iQOS device did reduce the body’s exposure to harmful or potentially harmful chemicals, it said iQOS did not reduce the risk for tobacco-related diseases.
In a press release, PMI officials said they would continue to work with the FDA on its modified-risk application. “As a next step, we look forward to working with the agency to clarify outstanding points so as to best assist in their ongoing decision-making process, which inherently entails a certain degree of scientific uncertainty premarket,” said Andre Calantzopoulos, CEO of PMI. “As the FDA routinely does with regard to the many products it regulates, I believe the agency will ultimately address that uncertainty in the best interest of people who smoke.”
The FDA still has to rule on PMI’s modified-risk tobacco product (MRTP) application, as well as its larger, separate application to sell iQOS in the United States.